| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses
|
Riederer, Stephanie
|
|
|
22 |
C |
p. 399-409
|
artikel
|
| 2 |
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?
|
Sumransub, Nuttavut
|
|
|
22 |
C |
p. 1-12
|
artikel
|
| 3 |
A gene expression-based immune content predictor for survival and postoperative radiotherapy response in head and neck cancer
|
Li, Yingqin
|
|
|
22 |
C |
p. 380-387
|
artikel
|
| 4 |
Annexin A8 regulated by lncRNA-TUG1/miR-140-3p axis promotes bladder cancer progression and metastasis
|
Yuan, Jun-Bin
|
|
|
22 |
C |
p. 36-51
|
artikel
|
| 5 |
An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model
|
Kitagawa, Koichi
|
|
|
22 |
C |
p. 592-603
|
artikel
|
| 6 |
A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors
|
Robb, Ryan
|
|
|
22 |
C |
p. 555-564
|
artikel
|
| 7 |
CD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells
|
Tay, Angelique Sao-Mai Sy
|
|
|
22 |
C |
p. 64-71
|
artikel
|
| 8 |
Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
|
Cao, Rui
|
|
|
22 |
C |
p. 277-293
|
artikel
|
| 9 |
Circular RNA SERPINE2 promotes development of glioblastoma by regulating the miR-361-3p/miR-324-5p/BCL2 signaling pathway
|
Li, Deheng
|
|
|
22 |
C |
p. 483-494
|
artikel
|
| 10 |
Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin
|
Gu, Yan-hui
|
|
|
22 |
C |
p. 565-573
|
artikel
|
| 11 |
Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma
|
Chao, Xiaoyu
|
|
|
22 |
C |
p. 209-218
|
artikel
|
| 12 |
Current strategies in engaging oncolytic viruses with antitumor immunity
|
Boagni, Drew Ashton
|
|
|
22 |
C |
p. 98-113
|
artikel
|
| 13 |
CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells
|
Li, Guangchao
|
|
|
22 |
C |
p. 507-517
|
artikel
|
| 14 |
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
|
Ho, Tiffany Y.
|
|
|
22 |
C |
p. 85-97
|
artikel
|
| 15 |
Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer
|
Zheng, Mingjun
|
|
|
22 |
C |
p. 294-306
|
artikel
|
| 16 |
Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells
|
Kim, Teddy E.
|
|
|
22 |
C |
p. 232-244
|
artikel
|
| 17 |
Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
|
Ma, Yu-Shui
|
|
|
22 |
C |
p. 326-335
|
artikel
|
| 18 |
E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms
|
Jiang, Wenxiao
|
|
|
22 |
C |
p. 518-527
|
artikel
|
| 19 |
Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas
|
Wei, Q.T.
|
|
|
22 |
C |
p. 114-128
|
artikel
|
| 20 |
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications
|
Shin, Charles
|
|
|
22 |
C |
p. 166-179
|
artikel
|
| 21 |
Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
|
Kang, Kai
|
|
|
22 |
C |
p. 431-443
|
artikel
|
| 22 |
Helicobacter pylori promotes gastric cancer progression by upregulating semaphorin 5A expression via ERK/MMP9 signaling
|
Pan, Guoqing
|
|
|
22 |
C |
p. 256-264
|
artikel
|
| 23 |
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation
|
Farrera-Sal, Martí
|
|
|
22 |
C |
p. 27-35
|
artikel
|
| 24 |
Imaging CAR T-cell kinetics in solid tumors: Translational implications
|
Skovgard, Matthew S.
|
|
|
22 |
C |
p. 355-367
|
artikel
|
| 25 |
lncRNA DSCR8 mediates miR-137/Cdc42 to regulate gastric cancer cell proliferation, invasion, and cell cycle as a competitive endogenous RNA
|
Chen, Zhengwei
|
|
|
22 |
C |
p. 468-482
|
artikel
|
| 26 |
Long non-coding RNAs and circular RNAs in tumor angiogenesis: From mechanisms to clinical significance
|
Liu, Chen-Guang
|
|
|
22 |
C |
p. 336-354
|
artikel
|
| 27 |
LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma
|
Song, Kun
|
|
|
22 |
C |
p. 582-591
|
artikel
|
| 28 |
m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer
|
Ji, Fei
|
|
|
22 |
C |
p. 574-581
|
artikel
|
| 29 |
Metformin inhibits gastric cancer cell proliferation by regulation of a novel Loc100506691-CHAC1 axis
|
Tseng, Hui-Hwa
|
|
|
22 |
C |
p. 180-194
|
artikel
|
| 30 |
Metformin preferentially enhances the radio-sensitivity of cancer stem-like cells with highly mitochondrial respiration ability in HMPOS
|
Deguchi, Tatsuya
|
|
|
22 |
C |
p. 143-151
|
artikel
|
| 31 |
METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
|
Li, Ruyi
|
|
|
22 |
C |
p. 245-255
|
artikel
|
| 32 |
miR-519d-3p suppresses tumorigenicity and metastasis by inhibiting Bcl-w and HIF-1α in NSCLC
|
Choi, Jae Yeon
|
|
|
22 |
C |
p. 368-379
|
artikel
|
| 33 |
miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition
|
Wu, Yongyan
|
|
|
22 |
C |
p. 152-165
|
artikel
|
| 34 |
miR-301 regulates the SIRT1/SOX2 pathway via CPEB1 in the breast cancer progression
|
Jia, Yanjing
|
|
|
22 |
C |
p. 13-26
|
artikel
|
| 35 |
MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC
|
Tan, Peng
|
|
|
22 |
C |
p. 307-325
|
artikel
|
| 36 |
Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma
|
He, Sanxiu
|
|
|
22 |
C |
p. 604-616
|
artikel
|
| 37 |
Non-coding RNAs in melanoma: Biological functions and potential clinical applications
|
Peng, Qiu
|
|
|
22 |
C |
p. 219-231
|
artikel
|
| 38 |
Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis
|
Uchihashi, Toshihiro
|
|
|
22 |
C |
p. 388-398
|
artikel
|
| 39 |
Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation
|
Sugawara, Kotaro
|
|
|
22 |
C |
p. 129-142
|
artikel
|
| 40 |
Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
|
Suzuki, Takuma
|
|
|
22 |
C |
p. 265-276
|
artikel
|
| 41 |
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives
|
Tang, Ying
|
|
|
22 |
C |
p. 410-430
|
artikel
|
| 42 |
Progress and application of circulating tumor cells in non-small cell lung cancer
|
Qian, Huizhu
|
|
|
22 |
C |
p. 72-84
|
artikel
|
| 43 |
Regulatory role and mechanism of m6A RNA modification in human metabolic diseases
|
Zhang, Yuliang
|
|
|
22 |
C |
p. 52-63
|
artikel
|
| 44 |
Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling
|
Liu, Aibin
|
|
|
22 |
C |
p. 195-208
|
artikel
|
| 45 |
Single-cell transcriptomics reveal DHX9 in mature B cell as a dynamic network biomarker before lymph node metastasis in CRC
|
Liu, Huisheng
|
|
|
22 |
C |
p. 495-506
|
artikel
|
| 46 |
Systematic review of the immunological landscape of Wilms tumors
|
Palmisani, Francesca
|
|
|
22 |
C |
p. 454-467
|
artikel
|
| 47 |
Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma
|
Christie, John D.
|
|
|
22 |
C |
p. 539-554
|
artikel
|
| 48 |
TBC1D3 family is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma
|
Wang, Bei
|
|
|
22 |
C |
p. 528-538
|
artikel
|
| 49 |
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment
|
Jackson, Joseph W.
|
|
|
22 |
C |
p. 444-453
|
artikel
|
Tijdschrift beschrijving